Abstract

INTRODUCTION

Prostate cancer is the most common cancer among men population, and clinical suspicion of prostate cancer is typically based on digital rectal examination and/or the finding of elevated prostate spesific antigen (PSA). Nowadays MpMRI has an emerging role in diagnostic evaluation of prostate cancer. In this study, we aimed to evaluate the Prostate Imaging Reporting and Data System (Pi-RADS) scores with the results of transrectal ultrasound (TRUS) guided targeted cognitif prostate biopsy.

METHODS

We evaluated the data of 40 patients who underwent MpMRI and TRUS cognitif biopsy due to suspicion of prostate cancer and/or ≥4 ng/ml PSA value and/or abnormal digital rectal examination at our clinic between August 2017 – January 2018. Patients age, PSA values and digital rectal examinations were recorded. A retrospectif review of Pi-RADS scores according to MpMRI and biopsi, Gleason scores were compared.

RESULTS

Overall, biopsies were positive in 24/40 patients. The mean age, the mean PSA value and the mean prostate volüme of patients were 64±9,4, 9,85±3,87 ng/ml and 61±18 g, respectively. Sensitivity, specificity, negative predictive value and pozitif predictive value of Pi-RADS scores according to MpMRI were 87.5%, 68.75%, 78% and 80.7%, respectively.

DISCUSSION AND CONCLUSION

MpMRI may be recommended for evaluation of prostate cancer suspicious cases and prostate biopsy will be performed according to Pi-RADS scores.